Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, H.-W.
Right arrow Articles by Legan, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, H.-W.
Right arrow Articles by Legan, S. J.
Agricola
Right arrow Articles by Tsai, H.-W.
Right arrow Articles by Legan, S. J.
Biology of Reproduction 64, 684-688 (2001)
© 2001 Society for the Study of Reproduction, Inc.


Regular Article

Chronic Elevation of Estradiol in Young Ovariectomized Rats Causes Aging-Like Loss of Steroid-Induced Luteinizing Hormone Surges1

Houng-Wei Tsaia, and Sandra J. Legan2,a

a Department of Physiology, University of Kentucky, Lexington, Kentucky 40536

ABSTRACT

This study was designed to test the hypothesis that the loss of LH surges in response to the stimulatory actions of estradiol and progesterone in middle-aged, persistent-estrous (PE) rats may be caused by chronic elevations in circulating estradiol. Five groups of regularly cycling young rats received an s.c. estradiol implant immediately after ovariectomy (Day 0). For determination of LH surges, blood samples were collected hourly between 1200–1900 h from each of the five groups at one of the following times: 3 days, or 1, 2, 4, or 8 wk later. On the next day, either progesterone (0.5 mg/100 g BW) or corn oil was injected s.c. at 1200 h, and samples were obtained as before. Incidence and amplitude of estradiol-induced LH surges decreased during the first 2 wk of estradiol treatment, after which no surges occurred. Progesterone enhanced the incidence and amplitude of estradiol-induced LH surges thus delaying their disappearance. These results support our hypothesis and demonstrate that the stimulatory actions of estradiol and progesterone on the LH surge sequentially diminish with time after exposure to estradiol in young rats. Thus, young rats chronically treated with estradiol may be a useful model for studying the mechanisms whereby LH surges are abolished in middle age during the hyperestrogenic state of PE.

aging, estradiol, LH surges, progesterone

INTRODUCTION

Among the first signs of reproductive aging in female rats are the attenuation and delayed onset of the proestrous LH surges that occur during middle age (9–10 mo) even in the presence of regular estrous cycles [15]. These modulations of the amplitude and timing of LH surges reflect age-related changes in the two mechanisms that control the LH surge in rodents, namely the response to the positive feedback action of estradiol and the circadian timing signal, respectively [6]. As rats age further, many of them experience a period of irregular cyclicity that is followed by an anovulatory state of persistent estrus (PE). During PE, follicular development continues to occur, as manifested by a chronic elevation in circulating estradiol concentrations to 30–40 pg/ml [7, 8], which in turn causes persistent vaginal cornification [7, 9]. By the time PE begins, the mechanisms mediating estradiol-induced LH surges are lost because the positive feedback action of estradiol no longer elicits an LH surge after ovariectomy unless followed by administration of progesterone [10]. However, even progesterone no longer induces LH surges after about 90 days of PE [10]. As rats age even further, the ability of progesterone to elicit LH surges in estradiol-primed rats returns, and the animals show repetitive pseudopregnancy [7]. This finding suggests that extinction of LH surges in PE rats is not totally caused by aging. This conclusion is supported by the observation that the stimulatory feedback action of estradiol in combination with progesterone on LH surges is functional in acutely ovariectomized repeat pseudopregnant rats but not in age-matched PE females [8].

Loss of the LH-surge-inducing action of estradiol is not unique to middle-aged PE rats. Indeed, exposure of young ovariectomized rats to estradiol causes a similar loss of LH surges within 2 wk [1113]. It is not known, however, whether response to the stimulatory action of progesterone in such rats is also lost, and if so, when. Based on these findings and on the previous considerations, it has been hypothesized that in aging PE rats, chronic exposure to the increased estradiol levels associated with acyclicity, rather than aging per se, causes the loss of steroid-induced LH surges [8, 14, 15]. Therefore, the following study was designed to investigate whether chronic exposure of young ovariectomized rats to elevated circulating estradiol levels would mimic the sequential loss of the stimulatory actions of estradiol and progesterone on LH surges that is observed in PE rats.

MATERIALS AND METHODS

Animals

Young (2-mo-old) female Sprague-Dawley rats (Zivic-Miller Laboratories Inc., Zelienople, PA) were maintained under constant conditions of temperature (22–24°C) and photoperiod (14L:10D, lights-on 0500 h). Food and water were provided ad libitum. Daily vaginal smears were monitored for 3–4 wk to determine estrous cyclicity. Only females that showed at least two consecutive 4-day estrous cycles were used.

Experimental Design

To investigate the effect of chronic estradiol treatment on the positive feedback action of estradiol and the LH surge-enhancing effect of progesterone, 51 regularly cycling rats were bilaterally ovariectomized (Day 0). Rats weighing from 201–370 g (mean ± SEM, 271.3 ± 5.2 g) were ovariectomized between the ages of 85 and 119 days (averaging 94.1 ± 1.3 days). Neither the age nor body weight (BW) were different among the groups at time of ovariectomy. Immediately thereafter, a 5-mm Silastic capsule (Dow Corning Co., Midland, MI) containing crystalline estradiol-17ß (Sigma Chemical Co., St. Louis, MO), prepared as described previously [16], was inserted s.c. Such implants have previously been reported to generate sustained plasma estradiol concentrations averaging about 75 pg/ml [16]. The rats were randomly divided into five groups that were tested on Day 3 (0.5 wk), or 1, 2, 4, or 8 wk after estradiol treatment (n = 11, 11, 12, 9, and 8, respectively). Blood samples (0.2 ml) were obtained hourly between 1200–1900 h for 2 days via a right atrial cannula that was inserted on the day before sampling. On the second day of sampling, either progesterone (0.5 mg/100 g BW, n = 6, 6, 7, 5, and 4) or corn oil vehicle (0.1 ml/100 g BW, n = 5, 5, 5, 4, and 4) was injected s.c. at 1200 h. The plasmas were separated and stored at -20°C until determination of LH concentrations by RIA.

At the time of sampling, the rats receiving estradiol for 8 wk were about 1–2 mo older than the animals in the other groups. Therefore, to determine whether this age difference contributes to the diminution of LH surges, 3-mo-old (96.1 ± 5.7 days, n = 15) and 5-mo-old (134.8 ± 9.3 days, n = 5) regularly cycling rats were ovariectomized and immediately treated with estradiol implants (Day 0). They were cannulated on Day 2, and at 1200 h on Day 3 they received an s.c. injection of either corn oil (n = 8 and 2, respectively) or progesterone (n = 7 and 3, respectively). Blood samples were obtained hourly between 1200–1700 h, and the plasmas were processed as described previously.

Radioimmunoassay

Plasma LH levels were determined in three aliquots, a single 20-µl and duplicate 5-µl aliquots, by means of a previously described rat LH assay [17] with the following modifications. CSU 120 (Dr. Terry Nett, Colorado State University, Fort Collins, CO) was used as the first antibody at a working dilution of 1:10 000. Iodinated rat LH (12 000 cpm/100 µl buffer) was obtained from Covance Laboratories, Inc. (Vienna, VA), and second antibody, goat anti-rabbit IgG, was obtained from Linco Research Inc. (St. Charles, MO). The tubes were incubated at 4°C for 48 h following the addition of each reagent. Plasma LH concentrations are reported in terms of ng RP-3 per ml, provided by the National Hormone and Pituitary Program. The sensitivity of the assay (100% minus 2 SD of maximum binding) averaged 0.03 ng/tube, and the interassay coefficient of variation was 8.3% for an intact serum pool that inhibited binding of labeled hormone to 79.5% of maximal binding.

Data Analyses

Both age and BWs were compared separately among groups by one-way ANOVA. An LH surge was defined as an increase in plasma LH concentrations of 2 SD above the mean value at 1200 h (1.54 ± 0.52 ng/ml) for at least two consecutive samples [18]. The numbers of rats with LH surges from each group were compared by chi-square tests. Only results from the groups in which more than two rats had LH surges were used in the statistical analyses. Peak LH levels on sampling Day 1 and 2 were compared by one-way and two-way ANOVA, respectively, to reveal the main effects of duration of estradiol treatment, progesterone administration, and their interaction. If there was a significant interaction (P < 0.05), post hoc comparisons were made using Tukey's test.

RESULTS

Age and BW of Rats

At the time of sampling, rats sampled after 8 wk of treatment were older than those in all other groups, and the animals sampled after 2 and 4 wk of exposure to estradiol were older than those in the 3-day and 1-wk groups (Fig. 1, upper panel). The only difference among groups in BW was between the heaviest and lightest groups, i.e., the rats treated for 8 wk weighed more than the 1-wk rats (Fig. 1, lower panel).



View larger version (50K):
[in this window]
[in a new window]
 
FIG. 1. Ages (upper panel) and BWs (lower panel) at the time of sampling in ovariectomized rats bearing s.c. estradiol (E2) implants for 0.5 (3 days), 1, 2, 4, and 8 wk. In the upper panel, different letters (a, b, and c) above the bars indicate values that are significantly different (P < 0.05). In the lower panel, the symbol (*) on the top of the two bars indicates means that are different from each other (P < 0.05)

Response to the Positive Feedback Action of Estradiol on Sampling Day 1

The longer the duration of exposure to estradiol, the lower the incidence and amplitude of LH surges (Fig. 2). Thus, 3 days (0.5 wk), and 1 and 2 wk after estradiol treatment, 9 of 11 (82%), 5 of 11 (45%), and 2 of 12 (17%) rats displayed an LH surge (Fig. 2, left panel). The peak levels of the LH surges averaged 15.24 ± 3.27 (3-day), 6.62 ± 2.33 (1-wk), and 4.96 ± 0.23 (2-wk) ng/ml, which occurred at 1600, 1700, and 1700 h, respectively (Fig. 2, right panel). There were no LH surges in response to estradiol alone after 4 or 8 wk of treatment. Mean plasma LH concentrations in the rats that did not surge remained undetectable throughout the sampling period (data not shown).



View larger version (26K):
[in this window]
[in a new window]
 
FIG. 2. Suppression of the incidence (left panel) and amplitude (right panel) of LH surges by chronic exposure of young ovariectomized rats to estradiol (OVX+E2). Blood samples were collected hourly from 1200 to 1900 h at 0.5 (3 days), 1, 2, 4, and 8 wk after s.c. insertion of estradiol implants. The bars (left panel) depict the percentage of rats displaying LH surges on sampling Day 1. Mean (± SEM) plasma LH concentrations in those rats that surged are shown in the right panel

Enhancement of the Positive Feedback Action of Estradiol by Progesterone on Sampling Day 2

In those rats receiving corn oil vehicle on the second day of sampling (Fig. 3, upper panels), an LH surge occurred in 80% (four of five) of rats after 4 days (0.5 wk) of exposure to elevated estradiol levels. Two of these rats displayed LH surges on both sampling days, reflecting the circadian timing signal that can trigger daily LH surges. The mean peak level of the LH surges on Day 4 was 7.25 ± 2.47 ng/ml (n = 4) at 1700 h (Fig. 3, upper right panel). After 1 wk of pretreatment with estradiol, only one of five oil-treated rats had an LH surge on the second day that peaked at 8.04 ng/ml at 1600 h. This rat had not exhibited an LH surge on the previous day. No LH surges were observed on the second day of sampling in the ovariectomized rats exposed to elevated estradiol levels for 2 or more weeks. In oil- or progesterone-treated rats that did not surge, plasma LH concentrations remained undetectable throughout the sampling period (data not shown).



View larger version (35K):
[in this window]
[in a new window]
 
FIG. 3. Incidence (left panels) and amplitude (right panels) of LH surges in young ovariectomized rats exposed to chronic estradiol (OVX+ E2) on the second day of sampling (sampling Day 2). At 1200 h, either corn oil (oil, 0.1 ml/100 g BW, upper panels) or progesterone (P, 0.5 mg/100 g BW, lower panels) was injected s.c. Blood samples were collected hourly from 1200 to 1900 h. The bars (left panels) depict the percentage of rats displaying LH surges. Mean (± SEM) plasma LH concentrations in those rats that surged are shown in the right panels

In contrast to the virtual disappearance of the response to estradiol alone by 2 wk after treatment, the LH surge-enhancing action of progesterone remained vigorous in most rats bearing estradiol implants for 4 days, and 1 and 2 wk (Fig. 3, lower panels). Thus, an LH surge occurred in six of six, five of six, and five of seven progesterone-treated rats after 4 days, and 1 and 2 wk of estradiol treatment, respectively. The mean peak levels of progesterone-enhanced LH surges 4 days (16.83 ± 2.39 ng/ml) and 1 wk (12.56 ± 1.51 ng/ml) after exposure to elevated estradiol levels were greater than those in the oil-treated rats similarly primed with estradiol (P < 0.05, compare Fig. 3 upper and lower right panels). However, this surge-enhancing action of progesterone was also greatly diminished with longer durations of estradiol exposure. Namely, after 4 or 8 wk of exposure to increased estradiol levels, only one rat in each group displayed an LH surge after progesterone injection. Thus, exposure of young ovariectomized rats to chronic estradiol results in sequential loss of the positive feedback action of estradiol within the first 2 wk, and of the surge-enhancing effect of progesterone during the next 2 wk. These results indicate that the surge-enhancing action of progesterone delays the loss of LH surges that result from chronic exposure to elevated levels of estradiol (Fig. 4).



View larger version (29K):
[in this window]
[in a new window]
 
FIG. 4. Progesterone enhances maximum LH levels, and delays the disappearance of LH surges induced by exposure to chronically elevated estradiol (E2) levels. The maximal values of LH levels on sampling Day 2 from individual rats were plotted against the duration of estradiol treatment. The equation, y = y0 + a/x, describes the relationship depicted by the regression lines for both oil- and progesterone-treated rats

Comparison of Steroid-Induced LH Surges in 3- and 5-Month-Old Female Rats

To determine whether the lack of LH surges in those rats receiving estradiol for 8 wk was due in part to their age, the LH surge-inducing action of a 3-day estradiol treatment alone or with progesterone was compared between 3- and 5-mo-old rats. Three days after ovariectomy and estradiol implantation, all rats in both age groups displayed LH surges, with no difference in peak levels (3 mo, 7.38 ± 1.00 ng/ml at 1700 h; and 5-mo, 9.89 ± 2.60 ng/ml at 1600 h) (Fig. 5, upper panel). In addition, the LH surge-enhancing action of progesterone also elicited identical LH surges in both age groups (3-mo peak, 28.63 ± 6.90 ng/ml; and 5-mo, 26.97 ± 7.78 ng/ml) (Fig. 5, lower panel). These results demonstrate that there is no age difference up to 5 mo of age in the neuroendocrine mechanism whereby estradiol, alone or with progesterone, induces an LH surge.



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 5. Mean (± SEM) plasma LH concentrations in response to estradiol alone (upper panel) or with progesterone (lower panel) were the same at 3 and 5 mo of age. Three days after ovariectomy and estradiol treatment, either corn oil (oil, 0.1 ml/100 g BW, upper panel) or progesterone (P, 0.5 mg/100 g BW, lower panel) was injected s.c. at 1200 h. Blood samples were collected hourly from 1200 to 1700 h

DISCUSSION

The foregoing results are consistent with previous findings that a chronic increase in circulating estradiol levels elicits repetitive daily LH surges for at least 10 days in young ovariectomized rats [11, 19]. Such prolonged exposure to an elevation in estradiol is associated with a decline in the positive feedback action of estradiol on LH surges. This diminution of LH release is not only reflected in a gradual decrease in amplitude of the LH surges [1113, 20] but also as we have observed, in the proportion of rats showing LH surges. In some previous reports, the LH surges were abolished within 10 days [11, 13]. In other studies, LH surges were still observed 14–15 days after estradiol treatments; however, the amplitudes of these LH surges were greatly decreased, suggesting their imminent disappearance [12, 20]. In our study, LH surges were abolished in most rats by 14 days and in all rats by 28 days after estradiol treatment. This variability in the time of extinction of the positive feedback action of estradiol among studies may be due to differences in the strains of rats, doses of estradiol, sampling frequency, or interval between ovariectomy and estradiol treatment. In spite of these differences, the foregoing observations indicate that chronic exposure to elevated estradiol levels abolishes daily LH surges within approximately 2 wk.

It has been well established that progesterone can enhance the positive feedback action of estradiol by increasing the amplitude of LH surges in estrogen-primed rats [18, 2123]. The results presented herein demonstrate that progesterone also increases the proportion of ovariectomized rats showing LH surges within 4 or 8 days after estradiol treatment. Even after 2 wk of exposure to increased circulating estradiol levels, when the positive feedback action of estradiol alone is too weak to elicit any detectable rise in plasma LH, the enhancing action of progesterone is still manifested by the occurrence of low-amplitude LH surges. However, after 4 wk of estradiol treatment, most rats are completely refractory to induction of LH surges by estradiol either alone or with progesterone and remain so for up to 8 wk. These findings demonstrate for the first time that exposure of young rats to chronic estradiol causes a sequential loss of the stimulatory actions of estradiol first, followed by progesterone.

In addition to increasing the amplitude of LH surges, progesterone, when administered at 0900 h, advances LH surges by several hours in both intact proestrous [22] and ovariectomized estrogen-primed rats [14]. However, in the present study, progesterone injection at 1200 h did not advance the time of onset of LH surges. This finding is consistent with those reported previously, in which progesterone was administered at noon [21] or later [23]. Thus, the time of treatment determines whether or not progesterone advances LH surges.

The rats receiving estradiol for 8 wk (at the age of about 5 mo) were about 1–2 mo older at the time of sampling than the animals in the other groups. However, their lack of response was not an effect of age because both 3- and 5-mo-old young rats have similar LH surges in response to the positive feedback stimulation of estradiol alone or with progesterone. Thus, in young rats treated for up to 8 wk, it is the duration of exposure to an increase in circulating estradiol rather than age that causes loss of the stimulatory actions of estradiol and progesterone on LH surges.

The underlying mechanisms mediating the estradiol-induced loss of the stimulatory actions of estradiol and progesterone on LH surges in chronically treated rats are still unclear. One possibility is that the daily LH surges cause gradual depletion of pituitary LH stores or pituitary response or sensitivity to GnRH. It has been previously reported that even after chronic estradiol treatment has abolished LH surges, an i.v. injection of synthetic GnRH (50 ng/100 g BW) increases plasma levels of LH equally in both young and middle-aged PE rats [14]. To date, however, no dose response study has been performed under conditions of chronic versus acute estradiol treatment. An alternative mechanism whereby chronic estradiol abolishes LH surges might reside in the brain. Another possibility is that the high levels of circulating prolactin that are generally associated with chronic administration of estradiol inhibit LH release [13]. However, chronic administration of the dopamine agonist, bromocriptine, to rats that have been exposed to elevated estradiol levels for 2 wk only partially restores LH surges [13]. This finding indicates that other as yet undetermined factors may also play important roles in the mechanism whereby chronic estradiol suppresses LH surges.

A similar sequential loss of the stimulatory actions of estradiol and progesterone on LH surges in the presence of chronically elevated estradiol levels (30 pg/ml) also occurs naturally during aging. In PE middle-aged rats, estradiol alone no longer induces LH surges [24]. During the early phase of PE (30–40 days), however, progesterone can still enhance the effect of estradiol and thereby elicit LH surges [10]. After a prolonged duration of PE, estradiol cannot trigger LH surges, either alone or with progesterone [8, 10, 14, 24]. Thus, the neuroendocrine responses of the LH surge mechanism to estradiol and progesterone in early PE and long-term PE rats are similar to those in young rats after 2 or 4 wk of exposure to estradiol, respectively. It is important to note, however, that in PE rats, circulating levels of estradiol average 30 pg/ml [7, 8]. These levels are about 50% lower than those reported in young rats after insertion of estradiol implants identical to those used in this study [16]. Finally, the difference in age between intact PE rats and chronically estradiol-treated young rats must be considered before drawing any conclusions about PE rats from results obtained in young rats.

In summary, the current results, in conjunction with previous findings, suggest that the sustained increase in circulating estradiol that occurs with aging may cause a sequential loss of the stimulatory actions of estradiol and progesterone on the LH surge in middle-aged rats. Further, the same mechanism that mediates the estradiol-induced loss of LH surges in young rats may cause loss of cyclicity in middle age. If this is the case, young rats chronically treated with estradiol would serve as an ideal model for investigating the mechanism whereby LH surges disappear during aging.

ACKNOWLEDGMENTS

We gratefully acknowledge Dr. Terry Nett for kindly providing the anti-rat LH antibody and Mr. Hunter Callahan for his expert assistance with the LH RIA.

FOOTNOTES

First decision: 3 August 2000.

1 Supported by NIH grants R01-AG13454 (S.J.L.), T32-AG00242, and F31-MH12289 (H.-W.T.). Back

2 Correspondence: Sandra Legan, Department of Physiology, University of Kentucky, 800 Rose Street, Lexington, KY 40536-0298. FAX: 859 323 1070; sjlegan{at}pop.uky.edu Back

Accepted: October 3, 2000.

Received: July 10, 2000.

REFERENCES

  1. Cooper RL, Conn PM, Walker RF. Characterization of the LH surge in middle-aged female rats. Biol Reprod 1980; 23:611–615.[Abstract]
  2. Gray GD, Tennent B, Smith ER, Davidson JM. Luteinizing hormone regulation and sexual behavior in middle-aged female rats. Endocrinology 1980; 107:187–194.[Medline]
  3. Lu JKH, LaPolt PS, Nass TE, Matt DW, Judd HL. Relation of circulating estradiol and progesterone to gonadotropin secretion and estrous cyclicity in aging female rats. Endocrinology 1985; 116:1953–1959.[Abstract]
  4. Nass TE, LaPolt PS, Judd HL, Lu JKH. Alterations in ovarian steroid and gonadotropin secretion preceding the cessation of regular oestrous cycles in ageing female rats. J Endocrinol 1984; 100:43–50.[Abstract]
  5. Wise PM. Alterations in proestrous LH, FSH, and prolactin surges in middle-aged rats. Proc Soc Exp Biol Med 1982; 169:348–354.[Medline]
  6. Wise PM. Estradiol-induced daily luteinizing hormone and prolactin surges in young and middle-aged rats: correlations with age-related changes in pituitary responsiveness and catecholamine turnover rates in microdissected brain areas. Endocrinology 1984; 115:801–809.[Abstract]
  7. Lu KH, Hopper BR, Vargo T, Yen SSC. Chronological changes in sex steroid, gonadotropin and prolactin secretion in aging female rats displaying different reproductive states. Biol Reprod 1979; 21:193–203.[Abstract]
  8. Lu JKH, Damassa DA, Gilman DP, Judd HL, Sawyer CH. Differential patterns of gonadotropin responses to ovarian steroids and to LH-releasing hormone between constant-estrous and pseudopregnant states in aging rats. Biol Reprod 1980; 23:345–351.[Abstract]
  9. Meites J, Huang HH. Relation of neuroendocrine system to loss of reproductive function in aging rats. In: Kumar A (ed.), Neuroendocrine Regulation of Fertility. Basel: Karger; 1976: 246–258.
  10. Tsai H-W, Hong L-S, LaPolt PS, Lu JKH. Gonadotropin surges elicited by progesterone after estradiol (E2)-priming, but not by E2 alone, in middle-aged, acyclic female rats exhibiting early persistent estrus. In: Program of the 10th International Congress of Endocrinology (P1-348); 1996; San Francisco, CA; 221.
  11. Legan SJ, Karsch FJ. A daily signal for the LH surge in the rat. Endocrinology 1975; 96:57–62.[Abstract]
  12. Chazal G, Faudon M, Gogan F, Hery M, Kordon C, Laplante E. Circadian rhythm of luteinizing hormone secretion in the ovariectomized rat implanted with oestradiol. J Endocrinol 1977; 75:251–260.[Abstract]
  13. Bethea CL, Weiner RI. Inhibition of prolactin secretion delays extinction of circadian LH surges in ovariectomized rats bearing estradiol implants. Proc Soc Exp Biol Med 1983; 172:65–69.[Abstract]
  14. Lu JKH, Gilman DP, Meldrum DR, Judd HL, Sawyer CH. Relationship between circulating estrogens and the central mechanisms by which ovarian steroids stimulate luteinizing hormone secretion in aged and young female rats. Endocrinology 1981; 108:836–841.[Medline]
  15. Finch CE, Felicio LS, Mobbs CV, Nelson JF. Ovarian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr Rev 1984; 5:467–497.[Abstract]
  16. Legan SJ, Coon GA, Karsch FJ. Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology 1975; 96:50–56.[Medline]
  17. Legan SJ, Callahan WH. Suppression of tonic luteinizing hormone secretion and norepinephrine release near the GnRH neurons by estradiol in ovariectomized rats. Neuroendocrinology 1999; 70:237–245.[CrossRef][Medline]
  18. Blake CA, Elias KA, Huffman LJ. Ovariectomy of young adults rats has a sparing effect on the ability of aged rats to release luteinizing hormone. Biol Reprod 1983; 28:575–585.[CrossRef][Medline]
  19. Henderson SR, Baker C, Fink G. Effect of oestradiol-17ß exposure on the spontaneous secretion of gonadotropins in chronically gonadectomized rats. J Endocrinol 1977; 73:455–462.[Abstract]
  20. Ratka A, Simpkins JW. Dose-dependent effects of chronic treatment with estradiol or progesterone on LH secretion in ovariectomized rats. Endocr Res 1990; 16:165–184.[Medline]
  21. Caligaris L, Astrada JJ, Taleisnik S. Biphasic effect of progesterone on the release of gonadotropin in rats. Endocrinology 1971; 89:331–337.[Medline]
  22. Brown-Grant K, Naftolin F. Facilitation of luteinizing hormone secretion in the female rat by progesterone. J Endocrinol 1972; 53:37–46.[Medline]
  23. Freeman MC, Dupke KC, Croteau CM. Extinction of the estrogen-induced daily signal for LH release in the rat: a role for the proestrous surge of progesterone. Endocrinology 1976; 99:223–229.[Abstract]
  24. Matt DW, Coquelin A, Lu JKH. Neuroendocrine control of luteinizing hormone secretion and reproductive function in spontaneously persistent-estrous aging rats. Biol Reprod 1987; 37:1198–1206.[Abstract]



This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
T. R. Chakraborty and A. C. Gore
Aging-Related Changes in Ovarian Hormones, Their Receptors, and Neuroendocrine Function
Experimental Biology and Medicine, November 1, 2004; 229(10): 977 - 987.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H.-W. Tsai, P. S. LaPolt, A. P. Olcott, and J. K.H. Lu
Temporal Changes Occur in the Neuroendocrine Control of Gonadotropin Secretion in Aging Female Rats: Role of Progesterone
Biol Reprod, September 1, 2004; 71(3): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. A. Birch, V. Padmanabhan, D. L. Foster, W. P. Unsworth, and J. E. Robinson
Prenatal Programming of Reproductive Neuroendocrine Function: Fetal Androgen Exposure Produces Progressive Disruption of Reproductive Cycles in Sheep
Endocrinology, April 1, 2003; 144(4): 1426 - 1434.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, H.-W.
Right arrow Articles by Legan, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, H.-W.
Right arrow Articles by Legan, S. J.
Agricola
Right arrow Articles by Tsai, H.-W.
Right arrow Articles by Legan, S. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS